158 related articles for article (PubMed ID: 18980999)
21. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder.
Mehra R; Storfer-Isser A; Kirchner HL; Johnson N; Jenny N; Tracy RP; Redline S
Arch Intern Med; 2006 Sep; 166(16):1725-31. PubMed ID: 16983050
[TBL] [Abstract][Full Text] [Related]
22. Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever (FMF) patients and their first degree relatives.
Oktem S; Yavuzsen TU; Sengül B; Akhunlar H; Akar S; Tunca M
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S34-6. PubMed ID: 15515781
[TBL] [Abstract][Full Text] [Related]
23. Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients.
Dziedzic T; Gryz EA; Turaj W; Slowik A; Szczudlik A
J Mol Neurosci; 2004; 24(2):293-8. PubMed ID: 15456942
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma.
Stasi R; Brunetti M; Parma A; Di Giulio C; Terzoli E; Pagano A
Cancer; 1998 May; 82(10):1860-6. PubMed ID: 9587117
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.
Soresi M; Giannitrapani L; D'Antona F; Florena AM; La Spada E; Terranova A; Cervello M; D'Alessandro N; Montalto G
World J Gastroenterol; 2006 Apr; 12(16):2563-8. PubMed ID: 16688802
[TBL] [Abstract][Full Text] [Related]
26. Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer.
Won HS; Kim YA; Lee JS; Jeon EK; An HJ; Sun DS; Ko YH; Kim JS
Cancer Invest; 2013 Oct; 31(8):516-21. PubMed ID: 23902164
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
[TBL] [Abstract][Full Text] [Related]
28. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
[TBL] [Abstract][Full Text] [Related]
29. Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction.
Kaminski KA; Kozuch M; Bonda T; Wojtkowska I; Kozieradzka A; Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Winnicka MM; Musial WJ
Atherosclerosis; 2009 Oct; 206(2):581-7. PubMed ID: 19406401
[TBL] [Abstract][Full Text] [Related]
30. mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis.
Träger C; Vernby A; Kullman A; Ora I; Kogner P; Kågedal B
Int J Cancer; 2008 Dec; 123(12):2849-55. PubMed ID: 18814238
[TBL] [Abstract][Full Text] [Related]
31. Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.
Abrahamsen B; Bonnevie-Nielsen V; Ebbesen EN; Gram J; Beck-Nielsen H
J Bone Miner Res; 2000 Aug; 15(8):1545-54. PubMed ID: 10934653
[TBL] [Abstract][Full Text] [Related]
32. Compartmentalization of pro-inflammatory cytokines in tuberculous pleurisy.
Hoheisel G; Izbicki G; Roth M; Chan CH; Leung JC; Reichenberger F; Schauer J; Perruchoud AP
Respir Med; 1998 Jan; 92(1):14-7. PubMed ID: 9519218
[TBL] [Abstract][Full Text] [Related]
33. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].
Tang L; Luo Q; Zhou X; Xia R
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):165-7. PubMed ID: 11955323
[TBL] [Abstract][Full Text] [Related]
34. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
[TBL] [Abstract][Full Text] [Related]
35. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.
Weiss TW; Arnesen H; Seljeflot I
Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306
[TBL] [Abstract][Full Text] [Related]
36. Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.
Pulsatelli L; Boiardi L; Pignotti E; Dolzani P; Silvestri T; Macchioni P; Cantini F; Salvarani C; Facchini A; Meliconi R
Arthritis Rheum; 2008 Aug; 59(8):1147-54. PubMed ID: 18668607
[TBL] [Abstract][Full Text] [Related]
37. Analysis of soluble interleukin 6 receptor in cerebrospinal fluid in inflammatory and non-inflammatory conditions.
Azuma H; Moriyama T; Ikeda H; Oshima M; Okuno A; Sekiguchi S
Cytokine; 2000 Feb; 12(2):160-4. PubMed ID: 10671302
[TBL] [Abstract][Full Text] [Related]
38. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
39. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
[TBL] [Abstract][Full Text] [Related]
40. [Study on serum soluble interleukin-6 receptor levels in patients with malignant hematological diseases].
Li D; Yang J; Cui W; Ma C; Ma C; Ji E; Li J; Li G; Ma C
Zhonghua Xue Ye Xue Za Zhi; 1997 Nov; 18(11):577-80. PubMed ID: 15625895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
